Overview

  • Product nameGeldanamycin
  • Description
    Selective Hsp90 inhibitor
  • Biological descriptionSelective Hsp90 inhibitor. Binds the ATP site of Hsp90 and inhibits chaperone activity. A benzoquinone ansamycin antibiotic. Also inhibits the Hsp90 paralog GRP94. Exhibits various cellular actions including gene expression, cell proliferation, apoptosis and angiogenesis.
  • Purity> 98%

Properties

    References for Geldanamycin (ab120896)

    This product has been referenced in:
    • Lee CH  et al. Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells. Biochimie 94:1382-9 (2012). Read more (PubMed: 22445681) »
    • Roe SM  et al. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J Med Chem 42:260-6 (1999). Read more (PubMed: 9925731) »
    • Whitesell L  et al. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci U S A 91:8324-8 (1994). Read more (PubMed: 8078881) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120896.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"